Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere Insulin in Diabetes and Asthma
NCT00332826Phase 3Terminated
- Sponsor
- MannKind
- Start
- Jun 2006
- Primary completion
- Oct 2007
- Modality
- Biologic
- Countries
- 11
01
Overview
A Phase 3 trial of Technosphere insulin in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by MannKind. Started Jun 2006; status: terminated.
02
Drugs
Technosphere insulin
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00332826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332826.